Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.
Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.